Conatus Pharmaceuticals Inc. (CNAT) fell -7.08% or -0.34 to $4.53. It is around 471871 shares traded, which is 75.89% compare to the average total volume 621808. The market cap of CNAT is $137.08 million. The year to date change is -4.45%. The 52 week price range is from $3.22 to $7.95. Price of CNAT have changed -7.50% during last week. It have changed 1.14% over last month, 20.37% over last 3 months, 35.04% over last 6 months and 15.52% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNAT is 4.96. It is 9.49% above current price. The 200-day Moving Averages for CNAT is 4.75. It is 4.86% above current price. The 52-week High is 7.95. It is 75.50% from the current price. The 52-week Low is 3.22. It is -28.92% from current price.
There are some statistics of CNAT. It is has market cap $137.08 million. The share outstanding is 30.26 million. The average volume is 621808. The percent of top 15 Institution holding is 28.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNAT is -77.60%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNAT is -25.20%.